241 related articles for article (PubMed ID: 21737465)
1. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer.
Stine ZE; McGaughey DM; Bessling SL; Li S; McCallion AS
Hum Mol Genet; 2011 Oct; 20(19):3746-56. PubMed ID: 21737465
[TBL] [Abstract][Full Text] [Related]
2. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
Wang C; Mayer JA; Mazumdar A; Brown PH
Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
[TBL] [Abstract][Full Text] [Related]
3. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
Zheng ZZ; Xia L; Hu GS; Liu JY; Hu YH; Chen YJ; Peng JY; Zhang WJ; Liu W
Nucleic Acids Res; 2022 Oct; 50(18):10230-10248. PubMed ID: 36124682
[TBL] [Abstract][Full Text] [Related]
4. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
[TBL] [Abstract][Full Text] [Related]
5. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
6. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
[TBL] [Abstract][Full Text] [Related]
7. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
[TBL] [Abstract][Full Text] [Related]
8. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.
Theodorou V; Stark R; Menon S; Carroll JS
Genome Res; 2013 Jan; 23(1):12-22. PubMed ID: 23172872
[TBL] [Abstract][Full Text] [Related]
9. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
10. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
[TBL] [Abstract][Full Text] [Related]
11. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
12. Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells.
Angrisano T; Sacchetti S; Natale F; Cerrato A; Pero R; Keller S; Peluso S; Perillo B; Avvedimento VE; Fusco A; Bruni CB; Lembo F; Santoro M; Chiariotti L
Nucleic Acids Res; 2011 Mar; 39(6):1993-2006. PubMed ID: 20952403
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
14. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
[TBL] [Abstract][Full Text] [Related]
15. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
16. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner.
Gertz J; Reddy TE; Varley KE; Garabedian MJ; Myers RM
Genome Res; 2012 Nov; 22(11):2153-62. PubMed ID: 23019147
[TBL] [Abstract][Full Text] [Related]
17. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
19. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
